IL6R and Alzheimer disease: Discrepancies are described concerning IL-6 and its receptor (sIL-6R), with studies describing decrease of plasmatic IL-68,21 and sIL-6R8 in AD patients (compared to control), and others describing a stability of this cytokine in the same context20.